PlainPharmaWatch

CMS Open Payments · Program Year 2024

60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals reported $109,563.25 in payments to 10 physicians and teaching hospitals across 13 transactions.

$109.6K
Total payments
13
Transactions
10
Recipients
#1159
of 1,925 companies

60 Degrees Pharmaceuticals reported $109,563.25 in payments to 10 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1159 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $11.0K per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

The verdict

60 Degrees Pharmaceuticals pairs below-median payment volume with a moderately concentrated payment pattern.

#1159
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
2
payment categories

How 60 Degrees Pharmaceuticals ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

60 Degrees Pharmaceuticals's total vs. every reporting company

CMS Open Payments, Program Year 2024

$109,563 40th percentile higher than 40% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). This entry sits in this band. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for 60 Degrees Pharmaceuticals

Rank #1159 of 1,925 companies in CMS Open Payments for 2024 belongs to 60 Degrees Pharmaceuticals, which reported $109,563.25 across 13 transactions to 10 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $8.4K per transaction and $11.0K per recipient.

"Consulting Fee" leads the 2-category general-payment breakdown below at $4.8K (4.4% of the company's reported total, 5 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

60 Degrees Pharmaceuticals made 2 types of general payments. "Consulting Fee" is the largest category at $4.8K, 4.4% of the company's reported total.

How 60 Degrees Pharmaceuticals divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$4.8K2. Food and Beverage$430.50
Payment Type Amount Transactions
Consulting Fee $4.8K 5
Food and Beverage $430.50 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $5,230.50 (100.0%) of $5,230.50 in this company's General Payments records across 5 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for 60 Degrees Pharmaceuticals

The five named recipients with the highest reported General Payments from this company

Thomas Moorcroft$1.3KVirginia Savely$986.10Shannon Delaney$986.10Denis Bouboulis$986.10Richard Horowitz$986.10
  1. 1

    Thomas Moorcroft

    $1,286.10 across 2 reported transactions

  2. 2

    Virginia Savely

    $986.10 across 2 reported transactions

  3. 3

    Shannon Delaney

    $986.10 across 2 reported transactions

  4. 4

    Denis Bouboulis

    $986.10 across 2 reported transactions

  5. 5

    Richard Horowitz

    $986.10 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $8.4K. Average per recipient: $11.0K.

Total Amount

$109,563.25

Avg per Transaction

$8.4K

Avg per Recipient

$11.0K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

60 Degrees Pharmaceuticals Share

0.0%

#1159 by total payments

Frequently Asked Questions

How much did 60 Degrees Pharmaceuticals pay to physicians and hospitals in 2024?
0.0% of all industry payments reported to CMS Open Payments for 2024 came from 60 Degrees Pharmaceuticals, totaling $109,563.25 across 13 transactions to physicians and hospitals.
How many physicians received payments from 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals made payments to 10 physicians and teaching hospitals in 2024. The average payment per recipient was $11.0K.
What types of payments did 60 Degrees Pharmaceuticals make?
60 Degrees Pharmaceuticals made 2 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $4.8K, representing 4.4% of the company's reported total.
How does 60 Degrees Pharmaceuticals rank among pharmaceutical companies?
Out of 1,925 companies in the CMS Open Payments database for 2024, 60 Degrees Pharmaceuticals ranks #1159 by total payment amount.
What is the average payment size from 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals's 13 transactions to 10 recipients in 2024 averaged $8.4K per transaction.
Where does the payment data for 60 Degrees Pharmaceuticals come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download 60 Degrees Pharmaceuticals's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.